Delivery Order SPE2DR25D2104-SPE2DR26F3PCR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,465.51 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $37,819.00 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This competitively awarded, firm fixed-price contract was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $62,369.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,657.02 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by September 26, 2025. This non-competitive, firm fixed-price delivery order was issued on September 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency awarded a $2,473.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award was issued on October 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,001.46 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $15,433.50 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PCRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,595.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, competitive delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Repatha, a high-value pharmaceutical for cholesterol management, exemplifies AmerisourceBergen's role in supporting Defense Health Agency and other federal healthcare systems through competitive, firm fixed-price transactions ranging from nominal to substantial amounts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/14/25 |